C
DGX icon

Certuity’s Quest Diagnostics DGX Stock Holding History

Certuity’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$241K Sell
1,231
-328
-21% -$63.7K 0.02% 529
2025
Q4 		$271K Buy
1,559
+348
+29% +$63.4K 0.02% 451
2025
Q3 		$231K Buy
+1,211
New +$215K 0.02% 480

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Certuity's DGX Position: Q1 2026 in Review

Certuity reduced its Quest Diagnostics (DGX) stake by 21% in Q1 2026, selling an estimated $63.7K and leaving 1,231 shares worth $241K. The position accounts for 0.02% of the portfolio, ranked #529.

Certuity first reported a position in DGX in Q3 2025 and has held it in 3 quarters since. The position peaked at $271K in Q4 2025. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Certuity held 1,231 shares of Quest Diagnostics worth $241K as of Q1 2026.
  • Certuity sold 328 Quest Diagnostics shares in Q1 2026, an estimated $63.7K.
  • Quest Diagnostics made up 0.02% of Certuity's portfolio in Q1 2026, its #529 holding.
  • Certuity first reported a position in Quest Diagnostics in Q3 2025 and has held it in 3 quarters since.
  • Certuity's Quest Diagnostics position peaked at $271K in Q4 2025.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Certuity's 13F filing for Q1 2026, filed 11 May 2026.